News
RSMDF
23.35
NaN%
--
ResMed outlines Q4 2025 gross margin target of ~59.9% amid strong product launches
Seeking Alpha · 1d ago
Weekly Report: what happened at RSMDF last week (0414-0418)?
Weekly Report · 4d ago
Weekly Report: what happened at RSMDF last week (0407-0411)?
Weekly Report · 04/14 12:03
Weekly Report: what happened at RSMDF last week (0331-0404)?
Weekly Report · 04/07 12:03
Weekly Report: what happened at RSMDF last week (0324-0328)?
Weekly Report · 03/31 12:19
abrdn Australia Equity Fund Commentary For The Quarter Ended January 31, 2025
Seeking Alpha · 03/28 10:25
Weekly Report: what happened at RSMDF last week (0317-0321)?
Weekly Report · 03/24 12:03
Weekly Report: what happened at RSMDF last week (0310-0314)?
Weekly Report · 03/17 12:17
Weekly Report: what happened at RSMDF last week (0303-0307)?
Weekly Report · 03/10 12:19
Weekly Report: what happened at RSMDF last week (0224-0228)?
Weekly Report · 03/03 12:18
ResMed’s Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep
Barchart · 02/26 02:00
Weekly Report: what happened at RSMDF last week (0217-0221)?
Weekly Report · 02/24 12:18
Weekly Report: what happened at RSMDF last week (0210-0214)?
Weekly Report · 02/17 12:14
Revisiting ResMed In 2025: Strong Q2 Financial Results And The Growing Demand For Sleep Apnea Solutions
Seeking Alpha · 02/10 15:38
Weekly Report: what happened at RSMDF last week (0203-0207)?
Weekly Report · 02/10 12:05
John's December 2024 Retirement Income Update: Income Increased By 5.9% FY-2024
Seeking Alpha · 02/08 14:00
Weekly Report: what happened at RSMDF last week (0127-0131)?
Weekly Report · 02/03 12:12
ResMed targets 59-60% gross margins and expanded global reach for AirSense 11
Seeking Alpha · 01/31 02:11
Weekly Report: what happened at RSMDF last week (0120-0124)?
Weekly Report · 01/27 12:16
ResMed: Fully Valued With Medium-Term Challenges (Rating Downgrade)
Seeking Alpha · 01/24 19:59
More
Webull provides a variety of real-time RSMDF stock news. You can receive the latest news about Resmed through multiple platforms. This information may help you make smarter investment decisions.
About RSMDF
ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.